Name: The Timing of Toxicological Studies to Support Clinical Trials (en Inglés)
Price: 320.64 PEN
Availability: InStock
Author: Parkinson, C. ; McAuslane, N. ; Lumley, C.
ISBN: 9789401046237

portada The Timing of Toxicological Studies to Support Clinical Trials (en Inglés)

The Timing of Toxicological Studies to Support Clinical Trials (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Parkinson, C. ; McAuslane, N. ; Lumley, C.

Idioma

Inglés

N° páginas

150

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 0.9 cm

Peso

0.25 kg.

ISBN13

9789401046237

Categorías

Administración y gestión médicas
Farmacología
Farmacia/prescripción/dispensación

The Timing of Toxicological Studies to Support Clinical Trials (en Inglés)

Parkinson, C. ; Mcauslane, N. ; Lumley, C. (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 13 a 18 días háb.

S/ 712,53S/ 320,64

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

S/ 320,64

Llega entre el 17 Ago y el 25 Ago a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "The Timing of Toxicological Studies to Support Clinical Trials (en Inglés)"

Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and development process. The major objective of these Workshops has been to provide an international forum for regula- tory, academic and industry representatives to debate together, and suggest solutions to, specific problems. The meeting reported in this volume represents a departure from this approach, in that the par- ticipants were drawn largely from the pharmaceutical industry. Senior clinicians, pharmacologists and toxicologists from companies in Europe, the USA and Japan met in May 1994 to discuss a scientific rationale for the conduct of toxicity studies to support the clinical development of new medicines, and to begin to work towards an industry consensus. Achievement of such a consensus is seen as an important step in the process leading towards international harmon- isation of the recommendations on the timing of toxicity studies in relation to clinical trials.